Next on this list of coronavirus stocks, Aethlon Medical (AEMD – Free Report) has been a hot topic on this site. However, the recent hype has everything to do with the coronavirus. The company prides itself on addressing unmet global health needs. Its clinical-stage device called Hemopurifier combats things like cancer as well as viral infections.
As an FDA designated “Breakthrough Device” preclinical studies have validated applications to a broad spectrum of viral threats. Specific to a pandemic threat like variations of the flu, the Hemopurifier has captured H5N1 avian flu and H1N1 swine flu. Needless to say, not much has been announced by the company besides a few multi-million dollar capital raises.
Some of the net proceeds from these offerings were designated for the currently planned clinical trials for the Hemopurifier®. Whether or not that translates into an immediate solution for the coronavirus epidemic is still to be seen. Shares of AEMD closed down 7% on January 24.